Use conditions

Terms for OpenAntigens data and software

OpenAntigens is a research database and construct-design portal built from public biological resources plus OpenAntigens-generated computational annotations. These terms separate the OpenAntigens software, generated annotations, and third-party source data.

Summary

MaterialTermsNotes
OpenAntigens softwareApache License 2.0Applies to the project source code unless a file states otherwise.
OpenAntigens-generated annotationsCC BY 4.0Applies to OpenAntigens-created construct recommendations, classifications, computed summaries, derived report text, portal index metadata, and related derived annotations.
Third-party source dataOriginal source terms applySequences, structures, identifiers, disease associations, literature counts, and source annotations retain the terms, licenses, and citation expectations of the databases from which they were obtained.

These terms describe research-data reuse for this release. Legal review and source-database compliance remain the responsibility of the person or organization reusing the data.

Website analytics

OpenAntigens uses aggregate, cookieless analytics to understand how the portal and its downloadable resources are used. The Privacy and Analytics page describes what is measured, what is excluded, and how aggregate results may be reported to funders.

OpenAntigens code

The OpenAntigens software is released under the Apache License 2.0. This includes the portal renderer, command-line tools, data-retrieval code, analysis logic, and supporting scripts unless a specific file states otherwise.

Third-party source data

OpenAntigens reports may include or derive from third-party identifiers, protein sequences, AlphaFold structures and confidence metrics, PDB mappings, domain annotations, disease associations, literature counts, BLAST databases, and source links. Those materials retain the terms and citation requirements of their original providers.

Research use

OpenAntigens is a research-use computational resource. Diagnosis, clinical decision-making, regulatory submissions, therapeutic selection, manufacturability claims, and expression-performance claims require independent expert review and experimental validation.

Source database terms and attribution

The table summarizes major sources used by OpenAntigens. Official source terms control reuse requirements.

SourceUsed forLicense / terms summaryLink
UniProtReviewed protein records, sequences, features, topology, domains, PTMs, entry namesCopyrightable database content is under CC BY 4.0; attribution required.UniProt license
AlphaFold DBPredicted structures, pLDDT, PAE, structure visualizationsData are available under CC BY 4.0; AlphaFold predictions are theoretical models and provided as-is.AlphaFold DB
Thera-SAbDabTherapeutic-antibody target evidence retained in the canonical human target tablePublication and source terms apply; cite the Thera-SAbDab database publication.Thera-SAbDab publication
SURFYSurfaceome support and topology context retained in the canonical human target tablePublication and source terms apply; cite the in silico human surfaceome publication.SURFY publication
Uhlén human secretomeSecretome support retained in the canonical human target tablePublication and source terms apply; cite the human secretome publication.Human secretome publication
RCSB PDB / wwPDBExperimental structure evidence and construct-boundary precedentPDB archive and RCSB API data are available under CC0 1.0; attribution to original structure authors is encouraged.RCSB usage policy
Complex PortalCurated human complex membership and assembly contextEMBL-EBI terms and Complex Portal citation expectations apply.EMBL-EBI terms
GPCRdbGPCR class/family annotations, segment boundaries, generic residue numbering, conserved motif context, and GPCR-focused interpretationGPCRdb source-specific terms and citation expectations apply. Cite the main GPCRdb reference and any page-specific GPCRdb references relevant to reused annotations.GPCRdb citing GPCRdb web services
Open Targets PlatformIndirect and direct target-disease association scores, disease links, and disease-aware searchPlatform data are marked CC0 1.0; citation of Open Targets is expected in accordance with good scientific practice.Open Targets licence
NCBI RefSeq / NCBI Protein / NCBI GeneOrtholog protein accessions and sequences in RefSeq-backed reference tables, including mouse and cynomolgus fallback/provenance recordsNCBI places no restrictions on molecular data but cannot transfer rights that may belong to submitters or third parties; acknowledge NCBI/NLM where appropriate.NCBI policies
InterPro, Pfam, EMBL-EBI resourcesDomain/family annotations and family contextEMBL-EBI expects attribution and may apply source-specific terms; Pfam is CC0.EMBL-EBI terms
HGNC and EnsemblHuman gene symbols, family/paralog context, gene linksSource-specific terms and attribution expectations apply.HGNC Ensembl
PubTator3 / PubMedLiterature-hit counts and literature linksNCBI/NLM policies apply; article text and abstracts may have separate copyright conditions.PubTator3
CiteAbExternal antibody-search link for each targetCiteAb catalog content stays external to OpenAntigens downloads and reports.CiteAb

Download scope

OpenAntigens downloads contain derived annotations alongside source-derived fields such as accessions, sequences, structure-confidence values, BLAST hit descriptions, disease associations, and links. Original source terms remain attached to source-derived fields included in an OpenAntigens file.

Attribution

Recommended attribution: OpenAntigens, Institute for Protein Innovation, created by Andre A. R. Teixeira. For publications or redistributed datasets, include the portal build date, downloaded artifact name, OpenAntigens version when available, and the relevant source databases.

Endorsement

References or links to third-party databases, products, antibodies, structures, publications, or disease associations identify source material and external resources. They carry no endorsement by OpenAntigens, the Institute for Protein Innovation, the source database providers, or any listed institution.

Warranty

OpenAntigens is provided as-is and without warranties of accuracy, completeness, non-infringement, merchantability, fitness for a particular purpose, expression performance, antigenicity, developability, or suitability for any specific use.

Limitations and user responsibility

Construct recommendations, BLAST sequence similarity rankings, paralog/family matrices, disease associations, pLDDT/PAE interpretation, and cysteine/furin warnings are computational annotations. Independent review, experimental validation, biosafety review, intellectual-property review, and compliance with institutional, funder, journal, clinical, regulatory, and commercial requirements remain the responsibility of the person or organization using the data.

OpenAntigens data may be incomplete, stale, or affected by source-database updates, sequence-version changes, isoform differences, species-specific annotation gaps, alignment errors, structure-model uncertainty, and BLAST database composition.

Corrections, licensing questions, and takedown requests

Responsible creator and contact: Andre A. R. Teixeira, Institute for Protein Innovation, andre.teixeira@proteininnovation.org.

Contact us to report incorrect attribution, problematic redistribution of source data, stale or incorrect annotations, broken links, or data requiring correction or removal.